Thermo Fisher Scientific P/E Ratio

Thermo Fisher Scientific's p/e ratio stands at 36.87. That is above the Healthcare sector average of 21.65. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Thermo Fisher Scientific sits higher the Healthcare benchmark (21.65) with a P/E ratio of 36.87. That is roughly 70.3% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 36.87 is attractive depends on Thermo Fisher Scientific's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how Thermo Fisher Scientific's P/E ratio evolved across reporting periods, while the comparison chart places TMO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, P/E ratio is commonly used to spot outliers. Thermo Fisher Scientific's reading of 36.87 (sector avg 21.65) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.